- Report
- February 2024
- 132 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- May 2022
- 140 Pages
Global
From €3277EUR$3,600USD£2,783GBP
- Report
- May 2022
- 74 Pages
Middle East, Africa
From €1365EUR$1,500USD£1,160GBP
- Report
- April 2022
- 220 Pages
Global
From €2202EUR$2,419USD£1,870GBP
€3146EUR$3,456USD£2,672GBP
- Book
- January 2010
- 200 Pages
The Heart Failure Device market is a subset of the Cardiovascular Devices market, which includes a range of medical devices used to diagnose, treat, and monitor cardiovascular diseases. Heart Failure Devices are used to treat patients with congestive heart failure, a condition in which the heart is unable to pump enough blood to meet the body's needs. These devices include implantable cardiac defibrillators, cardiac resynchronization therapy devices, and left ventricular assist devices. Implantable cardiac defibrillators are used to detect and treat life-threatening arrhythmias, while cardiac resynchronization therapy devices are used to improve the coordination of the heart's pumping action. Left ventricular assist devices are used to support the heart's pumping action in patients with severe heart failure.
Some companies in the Heart Failure Device market include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and LivaNova. Show Less Read more